EGFR and gastric cancer: This hypothesis-driven approach was based on data emerging from proteome analyses of entinostat-treated gastric cancer cells, unexpectedly demonstrating the upregulation of EGFR and the EGFR ligand amphiregulin in cells exposed to this HDACi.